Embedded Files
The Center for Prostate Disease Research (CPDR) is a multidisciplinary translational research program within the USU Department of Surgery, and the John P. Murtha Cancer Center, focused on studying prostate cancer and prostate disease in the US Military Healthcare System. Established by Congress in 1992, CPDR fulfills its mission primarily through three principal programs: the Clinical Translational Research Center, the Basic Science Research Program, and the Tri-Service Multicenter Prostate Cancer Database.
The Center for Prostate Disease Research (CPDR) is a multidisciplinary translational research program within the USU Department of Surgery, and the John P. Murtha Cancer Center, focused on studying prostate cancer and prostate disease in the US Military Healthcare System. Established by Congress in 1992, CPDR fulfills its mission primarily through three principal programs: the Clinical Translational Research Center, the Basic Science Research Program, and the Tri-Service Multicenter Prostate Cancer Database.
These programs enable CPDR to conduct clinical research in collaboration with various military medical centers. CPDR consists of the comprehensive medical treatment and patient education clinic, located at Walter Reed National Military Medical Center (WRNMMC), and the state-of-the-art Dr. David G. McLeod Laboratory in Bethesda, MD.
The combined expertise of medical oncologists, research nurses and patient educators, scientists, genitourinary pathologists, biostatisticians, histologists and technicians allow for advanced technological resources and innovative collaborative research in prostate cancer and prostate disease.
CPDR 2nd Annual Scientific Retreat Group Photo, April 17, 2025, HJF Headquarters, Bethesda, MD
CPDR 2nd Annual Scientific Retreat Group Photo, April 17, 2025, HJF Headquarters, Bethesda, MD
CPDR Hosts 2nd Annual Scientific Retreat at HJF Headquarters - April 17, 2025
CPDR Hosts 2nd Annual Scientific Retreat at HJF Headquarters - April 17, 2025
The CPDR 2nd Annual Scientific Retreat took place on Thursday, April 17 at HJF HQ in Bethesda, and we hosted 150 participants both in-person and virtually. The event included ten distinguished speakers, national leaders in prostate cancer research, and four young scientists from Johns Hopkins University and CPDR. The highlight was the Keynote Address presented by Dr. Isla Garraway, from the University of California Los Angeles David Geffen School of Medicine and the VA Healthcare System, entitled: The VA Multi-OMICS Analysis Platform for Prostate Cancer (VA-MAPP) - Activating a Learning Healthcare System Model to Improve Outcomes for Veterans. The day's agenda featured four insightful sessions covering critical research areas: Genomics of Prostate Cancer, Tumor Immune Microenvironment, Next Generations Cancer Therapeutics, and Advance Molecular Biology of Lethal Prostate Cancer. The 2025 retreat concluded with an impactful presentation from Dr. Artie Shelton, veteran and prostate cancer survivor, and an engaging poster session and award ceremony.
Go to our 2025 Scientific Retreat page for more photos and event details
500+ scientific articles have been published in the past 32 years
Over 268K biospecimen units collected from 9K+ patients
32K military patients with prostate cancer data, integrated with 5 DoD and 1 civilian medical center in Multicenter National Database Study
CPDR Groundbreaking Discoveries
CPDR Groundbreaking Discoveries
Developed and validated emerging diagnostic, prognostic, and therapeutic approaches through a long term (since 1993) bio-molecular specimen bank (230,000 units from 7000+ patients), e.g., ERG oncoprotein-based stratification of prostate cancer (PMID: 22331093) and Oncotype DX Prostate Cancer test (PMID: 25465337, PMID: 26723180).
CPDR WRNMMC
CPDR WRNMMC
Walter Reed National Military Medical Center
Building 19, 3rd Floor
4954 North Palmer Rd. Bethesda, MD 20889-5600
Phone: (301) 319-2900
Report abuse